Low cholesterol levels are good markers for central hypothyroidism in case with dialysis using roxadustat

Serina Kita¹，Hiroshi Okuyama²，Takaya Kondo¹，Mizuki Hayashi¹，Shinichiro Nakao¹，Toshitaka Sawamura²，Keiji Fujimoto¹，Atsushi Nakagawa³，Hitoshi Yokoyama¹，Kengo Furuichi¹

Department of Nephrology, Kanazawa Medical University¹，Asanogawa General Hospital²，Department of Diabetology and endocrinology, Kanazawa Medical University³

Corresponding author　Kengo Furuichi

Kanazawa Medical University　Department of Nephrology

1-1 Daigaku, Uchinada, Kahoku, Ishikawa 920-0293, Japan

tel +81-76-286-2211 (ext 33401)

fax +81-76-286-2786　 E-mail: furuichi@kanazawa-med.ac.jp

Keywords： hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitors, low cholesterol levels, roxadustat, central hypothyroidism

Patient consent statement: Written informed consent was obtained from the patient to publish this report in accordance with the journal’spatient consent policy.